Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
P

P&K Skin Research Center Co Ltd
KOSDAQ:347740

Watchlist Manager
P&K Skin Research Center Co Ltd
KOSDAQ:347740
Watchlist
Price: 2 400 KRW -2.83% Market Closed
Market Cap: ₩72B
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

Operating Cash Flow
+
3Y
-9%
5Y
-36%
10Y
-
Investing Cash Flow
+
3Y
+27%
5Y
+77%
10Y
-
Financing Cash Flow
+
3Y
-
5Y
-
10Y
-

Cash Flow Statement
P&K Skin Research Center Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: KRW
Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
8 070
9 732
6 719
6 749
6 845
6 499
7 293
6 693
6 046
6 418
7 130
7 143
6 025
5 241
4 700
4 576
5 232
6 640
5 701
6 750
7 309
6 571
Depreciation & Amortization
910
1 132
845
879
1 011
1 129
1 260
1 375
1 374
1 415
1 468
1 541
1 611
1 674
1 735
1 789
1 824
1 836
1 848
1 871
1 923
1 996
Stock-Based Compensation
0
0
0
0
0
0
50
67
83
100
116
116
116
116
182
181
165
149
198
0
0
0
Other Non-Cash Items
1 038
1 216
721
399
207
(163)
(110)
(190)
(266)
(381)
(829)
(1 548)
281
(2 503)
(3 113)
(2 952)
(5 343)
(3 875)
(3 194)
(3 039)
(3 263)
(2 765)
Cash Taxes Paid
947
1 280
982
1 176
1 254
1 417
1 433
1 171
1 191
1 143
1 178
1 253
1 308
1 295
1 329
1 058
961
693
682
1 217
1 260
1 542
Cash Interest Paid
35
42
23
24
26
27
29
30
28
27
24
24
25
28
30
31
33
35
24
26
30
31
Change in Working Capital
(181)
(745)
382
(642)
23
19
(746)
1 140
135
430
(262)
1
(1 172)
1 312
2 227
2 509
5 217
4 407
4 677
2 709
2 088
1 409
Cash from Operating Activities
9 837
N/A
11 335
+15%
8 666
-24%
7 385
-15%
8 086
+9%
7 483
-7%
7 697
+3%
9 018
+17%
7 289
-19%
7 882
+8%
7 507
-5%
7 138
-5%
6 746
-5%
5 724
-15%
5 549
-3%
5 922
+7%
6 930
+17%
9 008
+30%
9 032
+0%
8 292
-8%
8 057
-3%
7 211
-10%
Investing Cash Flow
Capital Expenditures
(1 363)
(1 449)
(1 055)
(2 030)
(2 429)
(2 613)
(2 810)
(1 449)
(1 493)
(1 440)
(1 356)
(1 554)
(1 031)
(1 422)
(1 560)
(1 255)
(1 125)
(673)
(622)
(1 128)
(1 637)
(1 764)
Other Items
77
(37 293)
(36 357)
(37 590)
(40 320)
(1 255)
(7 002)
(5 914)
(5 897)
(10 750)
(2 964)
(6 875)
(5 241)
253
2 532
4 688
(380)
(1 877)
(8 252)
(11 305)
(7 383)
(7 137)
Cash from Investing Activities
(1 286)
N/A
(38 742)
-2 912%
(37 412)
+3%
(39 620)
-6%
(42 749)
-8%
(3 868)
+91%
(9 812)
-154%
(7 363)
+25%
(7 391)
0%
(12 191)
-65%
(4 320)
+65%
(8 429)
-95%
(6 272)
+26%
(1 168)
+81%
972
N/A
3 433
+253%
(1 505)
N/A
(2 550)
-69%
(8 874)
-248%
(12 434)
-40%
(9 020)
+27%
(8 901)
+1%
Financing Cash Flow
Net Issuance of Common Stock
0
27 574
25 522
0
0
0
0
0
0
1 386
1 495
0
0
0
(611)
(2 367)
(2 996)
(2 996)
(2 386)
0
0
0
Net Issuance of Debt
(242)
(293)
(206)
(203)
(217)
(243)
(264)
(294)
(309)
(314)
(318)
(327)
(339)
(357)
(373)
(383)
(390)
(393)
(394)
(404)
(425)
(447)
Cash Paid for Dividends
0
0
0
0
0
0
0
0
(893)
(893)
(893)
0
(872)
(872)
(872)
0
(715)
(715)
(715)
0
(977)
(977)
Other
(13)
0
(1 111)
0
0
0
0
0
0
0
0
149
149
149
149
0
0
0
0
0
0
0
Cash from Financing Activities
2 908
N/A
27 281
+838%
24 204
-11%
24 207
+0%
24 206
0%
(243)
N/A
(264)
-9%
(294)
-11%
(1 202)
-309%
179
N/A
284
+59%
424
+49%
432
+2%
(971)
N/A
(1 706)
-76%
(3 623)
-112%
(4 101)
-13%
(4 104)
0%
(3 495)
+15%
(1 748)
+50%
(1 402)
+20%
(1 424)
-2%
Change in Cash
Effect of Foreign Exchange Rates
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
(0)
1
1
0
0
Net Change in Cash
11 459
N/A
(125)
N/A
(4 542)
-3 522%
(8 027)
-77%
(10 457)
-30%
3 373
N/A
(2 379)
N/A
1 361
N/A
(1 303)
N/A
(4 129)
-217%
3 471
N/A
(867)
N/A
906
N/A
3 585
+296%
4 815
+34%
5 732
+19%
1 324
-77%
2 354
+78%
(3 336)
N/A
(5 889)
-77%
(2 365)
+60%
(3 113)
-32%
Free Cash Flow
Free Cash Flow
8 473
N/A
9 886
+17%
7 611
-23%
5 355
-30%
5 657
+6%
4 871
-14%
4 886
+0%
7 569
+55%
5 796
-23%
6 442
+11%
6 151
-5%
5 584
-9%
5 715
+2%
4 302
-25%
3 990
-7%
4 667
+17%
5 805
+24%
8 335
+44%
8 410
+1%
7 163
-15%
6 420
-10%
5 447
-15%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 318,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.